Back

Impact of levosimendan versus dobutamine on 30-day mortality and hospital stay in acute decompensated heart failure: a systematic review and meta-analysis

29 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure therapies: timing, choices, and comparative effectiveness Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hilson Amorim Parente

National Institute of Cardiology - Rua das Laranjeiras, Rio de Janeiro (Brazil)

5 More presentations in this session

Presentation thumbnail
SGLT2 inhibitor outcomes in elderly post-MI patients with mildly reduced ejection fraction: age-stratified real-world evidence
Doctor A. Ajibade (Iowa City, US)
Abstract
Presentation thumbnail
From trials to treatment: real-world vericiguat initiation and residual risk in Germany
Doctor F. Kerwagen (Wuerzburg, DE)
Abstract
Presentation thumbnail
Early in-hospital initiation of dapagliflozin versus empagliflozin in acute heart failure: impact on in-hospital survival and safety
Doctor N. Benameur (Tangier, MA)
Abstract
Presentation thumbnail
Does initiating SGLT2 inhibitors at an early stage of heart failure admission really reduce cardiovascular mortality and first rehospitalization? A meta-analysis of randomized controlled trials
Doctor E. Alupei (RO)
Abstract
Presentation thumbnail
Early catheter ablation for atrial fibrillation in acute heart failure: prognostic impact across age and ejection fraction
Doctor A. Okahara (Fukuoka, JP)
Abstract

Access the full session

Session thumbnail
Acute heart failure therapies: timing, choices, and comparative effectiveness

The Event

Event poster

ESC Congress 2026

29 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Levosimendan in acute heart failure: a tertiary center experience
29 June 2021
thumbnail
Congress Presentation
Meta-analysis comparing the efficacy of dobutamine versus milrinone in acute decompensated heart failure and cardiogenic shock.
27 August 2022
thumbnail
Congress Presentation
Global prevalence of in-hospital complications, mortality and LV recovery in women with PPCM - a systematic review and meta-analysis.
23 May 2022
thumbnail
Congress Presentation
Influence of adherence and optimal pharmacological treatment on survival rates of hospitalized patients with decompensated heart failure
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources